Pharmacokinetics of single dose cerivastatin in subjects with normal and impaired renal function

被引：0
|
作者：
Vormfelde, SV
Gleiter, CH
Freudenthaler, S
Muck, W
Schmage, N
Kuhlmann, J
GundertRemy, U
机构：
[1] UNIV GOTTINGEN,D-3400 GOTTINGEN,GERMANY
[2] BAYER AG,D-5600 WUPPERTAL,GERMANY
[3] BUNDESINST SUER GESUNDHEITLICHEN VERBRAUCHERSTHUT,BERLIN,GERMANY
来源：
ATHEROSCLEROSIS | 1997年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS AND DOSE RECOMMENDATIONS OF FLEROXACIN IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION
    HOFFLER, D
    PECH, M
    KOEPPE, P
    METZ, R
    SORGEL, F
    [J]. ACTA THERAPEUTICA, 1988, 14 (02) : 121 - 134
  • [2] Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function
    Treitel, Michelle
    Marbury, Thomas
    Preston, Richard A.
    Triantafyllou, Ilias
    Feely, William
    O'Mara, Edward
    Kasserra, Claudia
    Gupta, Samir
    Hughes, Eric A.
    [J]. CLINICAL PHARMACOKINETICS, 2012, 51 (09) : 619 - 628
  • [3] Single dose pharmacokinetics of lamivudine in subjects with impaired renal function and the effect of haemodialysis
    Johnson, MA
    Verpooten, GA
    Daniel, MJ
    Plumb, R
    Moss, J
    Van Caesbroeck, D
    De Broe, ME
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (01) : 21 - 27
  • [4] Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function
    Michelle Treitel
    Thomas Marbury
    Richard A. Preston
    Ilias Triantafyllou
    William Feely
    Edward O’Mara
    Claudia Kasserra
    Samir Gupta
    Eric A. Hughes
    [J]. Clinical Pharmacokinetics, 2012, 51 (9) : 619 - 628
  • [5] The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function
    Aweeka, F
    Jayesekara, D
    Horton, M
    Swan, S
    Lambrecht, L
    Wilner, KD
    Sherwood, J
    Anziano, RJ
    Smolarek, TA
    Turncliff, RZ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 : 27S - 33S
  • [6] Pharmacokinetics of glucarpidase in subjects with normal and impaired renal function
    Phillips, Marc
    Smith, William
    Balan, Guhan
    Ward, Suzanne
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (03): : 279 - 284
  • [7] Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Normal or Varying Degrees of Impaired Renal Function
    Mayer M.
    Nudurupati S.
    Peng X.
    Marcinak J.
    [J]. Drugs in R&D, 2014, 14 (4) : 273 - 282
  • [8] DOSE-DEPENDENT PHARMACOKINETICS OF MEZLOCILLIN IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION
    MANGIONE, A
    JANICKE, DM
    BOUDINOT, FD
    SCHULTZ, RM
    JUSKO, WJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 9 : 81 - 85
  • [9] The single-dose pharmacokinetics of carisbamate in subjects with normal and impaired hepatic function.
    Moore, K. T.
    Zannikos, P.
    Solanki, B.
    Greenspan, A.
    Romano, G.
    Brashear, H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S24 - S24
  • [10] PHARMACOKINETICS OF CEFOTAXIME IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION
    FILLASTRE, JP
    LEROY, A
    HUMBERT, G
    GODIN, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 : 103 - 111
12345